by Steven Grossman | Feb 20, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. 1. FDA At Risk on Four FrontsAll the federal public health programs are under siege. While my focus is on FDA, I want readers to know that NIH and CDC...
by Steven Grossman | Feb 18, 2025 | Short Takes and Updates
FDA employees—public-spirited and committed—are the heart of the agency and can proudly point to a lengthy record of accomplishment. Our country has safe food and safe and effective medical products because of their efforts. We are all affected: every American uses...
by Steven Grossman | Feb 14, 2025 | Short Takes and Updates
If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. 1. When Will Congress Engage on the Future of FDA User Fees?Either the agency is captured by industry (Secretary Kennedy), or it is a hindrance to...
by Steven Grossman | Feb 12, 2025 | Short Takes and Updates
Permission is granted to reprint or recirculate this column, as long as attribution is made to FDA Matters (www.fdamatters.com) and the author. “A cynic knows the price of everything and the value of nothing.”—Oscar WildePart 1: Meaningful Deficit...
by Steven Grossman | Feb 6, 2025 | Short Takes and Updates
Today is the first “Short Takes and Updates” column. For those who have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to register. 1. US to Leave the World Health Organization—An Alternative Interpretation.For those who...
